IL18 and metabolic syndrome: Also, in humans, elevated circulating levels of IL-18, a product of the activation of the nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, have been identified in patients with metabolic syndrome (Yasuda et al., 2019).